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Background.  Although the diagnostic significance of isolating Aspergillus spp. from respiratory 
cultures has been studied in immunocompromised hosts with invasive pulmonary aspergillosis (IPA), little 
is known in immunocompetent patients with other forms of aspergillosis. In this study of adult pneumology 
ward patients, we examined the association between Aspergillus spp. and disease prevalence. 
Methods.  Laboratory records from April 1998 to March 2009 were reviewed to identify patients with 
Aspergillus spp. in respiratory samples. Correlations between the isolated species and clinical 
characteristics of patients were evaluated. 
Results.  During the study period, 165 Aspergillus spp. isolates were detected in the respiratory cultures 
of 139 patients. Of these patients, 62 (45%) were colonized with Aspergillus spp. and displayed no clinical 
symptoms of aspergillosis, while 77 (55%) had a form of pulmonary aspergillosis, characterized as either 
chronic necrotizing pulmonary aspergillosis (CNPA) (48%), aspergilloma (29%), IPA (13%), or allergic 
bronchopulmonary aspergillosis (ABPA) (10%). The dominant species were A. fumigatus (41%), A. niger 
(32%), and A. versicolor (12%). A. fumigatus was most commonly isolated in patients with IPA, 
aspergilloma, and CNPA, whereas A. niger was the dominant species in colonized patients and those with 
ABPA. 
Conclusions.  Isolation of an Aspergillus sp. from respiratory samples does not confirm it is the 
etiologic pathogen, because airway colonization by Aspergillus spp. is a common feature in several chronic 
lung diseases. Repeated isolation of the identical Aspergillus sp. and detection of anti-Aspergillus 
antibodies and/or Aspergillus antigens in sera are needed to determine the isolate that represents the 
etiologic organism.  
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INTRODUCTION 
Members of the genus Aspergillus are ubiquitous saprophytic fungi, and due to their widespread 
nature in the environment, the average person may inhale hundreds of Aspergillus conidia per day [1]. 
Conidia are typically removed from the respiratory tract by mucociliary clearance and phagocytosis by 
alveolar macrophages, while germinating spores and hyphae are attacked by polymorphonuclear 
neutrocytes through degranulation and the release of oxidants [2]. Despite these effective clearance 
mechanisms for the elimination of inhaled conidia from the respiratory tracts of healthy individuals, 
Aspergillus conidia are capable of colonizing injured lung tissue and epithelia. Although such colonization 
often has no clinical consequences, Aspergillus conidia can cause a variety of clinical manifestations 
depending on the immune status of the host [3, 4]. For example, allergic bronchopulmonary aspergillosis 
(ABPA), which encompasses hypersensitivity reactions to Aspergillus antigens, can develop in atopic 
patients [5, 6], while aspergilloma is mainly observed in patients with chronic cavitary lung disease. Other 
forms of aspergillosis include chronic necrotizing pulmonary aspergillosis (CNPA), which is seen in mildly 
immunocompromised patients and those individuals with chronic lung diseases [7], and invasive 
pulmonary aspergillosis (IPA), which is the most serious lung infection due to Aspergillus spp. and 
typically occurs only in severely immunocompromised patients [8]. 
Isolation of Aspergillus spp. from respiratory samples of a patient with suspected aspergillosis does 
not necessarily indicate that the identified species is the etiologic agents of disease. Although the diagnostic 
significance of isolation of Aspergillus spp. from respiratory cultures has been extensively examined in 
immunocompromised hosts who develop IPA [9–13], little is known with respect to the presence of 
Aspergillus spp. in the respiratory tracts of immunocompetent or mildly immunocompromised patients with 
other forms of aspergillosis [14–16]. Here, we conducted a retrospective study to evaluate the clinical 




MATERIALS AND METHODS 
The microbiology laboratory records of the Pneumology Department of Nagasaki University Hospital, 
Japan from April 1998 to March 2009 were reviewed to identify all patients who had Aspergillus spp. 
isolated from cultures of respiratory samples. A total of 350-500 patients including 150-200 new patients 
per year admitted to this department and most common lung disease is lung cancer. The respiratory samples, 
which included sputum, endotracheal aspirates, and bronchoalveolar lavage fluid, were obtained as a part of 
a diagnostic work-up for respiratory disease. Samples were immediately cultured in sabouraud dextrose 
agar (SDA) 10 days at 30 °C. Filamentous fungi in SDA was then transferred to potato dextrose agar and 
incubated for 2-3 days at 30 °C. The isolates were identified based upon macroscopic and microscopic 
morphological characteristics following standard mycological procedures. For each patient with a positive 
sample for Aspergillus, the species and clinical characteristics of the patient were recorded. When an 
identical species of Aspergillus was isolated on more than one occasion from the same patient, it was 
counted only once. 
Aspergilloma was diagnosed when a characteristic fungus ball was detected within a lung cavity by 
chest radiograph or computed tomography and a positive serological test (antibody detected) was obtained 
or Aspergillus spp. was isolated from respiratory samples. CNPA was diagnosed when chest radiographs 
showed a cavitary pulmonary lesion with evidence of paracavity infiltrates or cavitary change developing 
over a time-frame of several weeks to several months in patients with chronic pulmonary symptoms, 
elevated inflammatory markers, and positive serological tests (antigen/antibody detected) or isolation of 
Aspergillus spp. from respiratory samples [17]. IPA was diagnosed when chest radiographs showed acute 
and extensive pneumonia or nodular pneumonia resistant to broad-spectrum antibiotics in 
immunocompromised patients, and respiratory samples yielded Aspergillus spp. without pathogenic 
bacteria. ABPA was diagnosed according to the criteria of Rosenberg [5]. Serological tests including 
Aspergillus antibody and antigen tests were performed when the patients were suspected to have pulmonary 
aspergillosis. Patients were diagnosed as having airway colonization when Aspergillus spp., were isolated 
from respiratory samples without clinical or histological evidence of aspergillosis. The all of charts were 
reviewed by T.T., K.I., M.T., T.T., T.M., and H.K. as chart review committee. All of chart review committee 




During the 11-year study period, 165 isolates of Aspergillus spp. were detected from the cultures of 
respiratory samples of 139 patients. Of these patients, 62 (45%) were colonized with Aspergillus spp. but 
displayed no clinical symptoms of aspergillosis, while the remaining 77 (55%) had a form of pulmonary 
aspergillosis, which could be classified as CNPA (48%), aspergilloma (29%), IPA (13%), or ABPA (10%). 
The clinical characteristics of the patients are summarized in Table 1. 
The patients with CNPA or aspergilloma displayed a high occurrence of associated chronic lung 
disease, including chronic obstructive pulmonary disease (COPD), non-tuberculous mycobacteriosis 
(NTM), pulmonary tuberculosis, lung cancer, and bullae or a history of pneumothorax, interstitial 
pneumonia, and pneumoconiosis. In addition, the majority of patients with CNPA suffered from a mild 
systemic immunosuppressive condition, such as diabetes mellitus, solid-organ cancer, chronic liver disease, 
and corticosteroid or cytotoxic drug use. In patients with IPA, systemic immunosuppression due to 
hematologic malignancy, corticosteroid therapy, or chemotherapy were the major predisposing factors, 
while patients with ABPA often displayed bronchial asthma (88%) and/or other atopic diseases (63%). Of 
the 62 patients with Aspergillus colonization, nearly all had an associated chronic lung disease, such as 
tuberculosis, COPD, lung cancer, NTM, interstitial pneumonia, and/or an immunosuppressive condition 
induced by corticosteroid use, collagen vascular disease, solid-organ cancer other than lung, hematologic 
malignancy, or diabetes mellitus. In-hospital mortality was highest in patients with IPA (80%), whereas it 
was relatively low in patients with CNPA (16%), aspergilloma (5%), and Aspergillus colonization (2%). 
None of the patients with ABPA died during their hospitalization period. 
We determined the distribution of Aspergillus spp. among the 165 isolates from the respiratory 
cultures of 139 patients (Table 2). The two dominant species of Aspergillus were A. fumigatus (41%) and A. 
niger (32%), with A. versicolor (12%), A. terreus (6%), A. flavus (5%), A. nidulans (2%), A. sydowii (1%), 
and unidentifiable Aspergillus spp. (0.6%) accounting for the remaining isolates. When the patient data 
between 1998 and 2004 were compiled, A. fumigatus was the most commonly isolated species (58.2%), 
followed by A. niger (20.9%), A. flavus (10.4%), A. versicolor (6.0%), and A. terreus (4.5%). However, 
between 2005 and 2009, the incidence of A. fumigatus isolation decreased by approximately half (28.6%), 
whereas that of A. niger isolation increased approximately two fold (39.8%), with A. versicolor (16.3%) 
and A. terreus (7.1%) again being the next most common isolates (Figure 1). 
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To gain a better understanding of the diagnostic significance of the presence of Aspergillus spp. in 
respiratory samples, we examined the correlation between the identified species and the clinical 
characteristics of patients with respect to disease. It was revealed that A. fumigatus was the most commonly 
isolated species in patients with IPA (82%), aspergilloma (68%), and CNPA (54%), while A. niger was the 
second most prevalent isolate in patients with these diseases. In patients with ABPA, A. niger was the most 
common isolate (40%), followed by A. fumigatus (30%). A. niger was also the most common isolate (48%) 
in patients asymptomatic for aspergillosis, followed by A. versicolor (20%) and A. fumigatus (16%). 
Interestingly, with respect to colonization of Aspergillus species, 70% (14/20) and 62% (33/53) of cases of 
A. versicolor and A. niger isolation, respectively, were considered as asymptomatic colonization, whereas 
only 16% (11/67) of cases of A. fumigatus isolation were not associated with disease. 
Finally, we examined the respiratory tract colonization profiles and patterns among the 139 patients 
positive for Aspergillus spp. In most patients (83%), only a single Aspergillus spp. was isolated from 
respiratory tract samples, whereas two or more species were isolated in the remaining patients (17%). In 17 
of these 23 patients, a synchronous isolation pattern was observed, which was characterized by isolation of 
two or more species in the same sample or different samples obtained within a 1-month period (Table 3). 
The remaining six patients displayed a metachronous isolation pattern, in which different samples obtained 
with an interval of over 1 month was revealed (Table 4). The combination of A. fumigatus and A. niger was 





Although the genus Aspergillus consists of approximately 200 species [2, 18], only a few are 
considered human pathogens and generally require immunocompromised hosts to cause disease. Among 
Aspergillus spp., A. fumigatus is the primary causative agent of human infections, followed by A. flavus, A. 
terreus, A. niger, and A. nidulans [8, 19–26]. In the present retrospective study, A. fumigatus was the most 
commonly isolated species from respiratory samples, followed by A. niger, A. versicolor, A. terreus, A. 
flavus, A. nidulans, and A. sydowii. However, our analysis of laboratory records and clinical disease 
revealed that the isolation of a particular Aspergillus spp. does not confirm it is the etiologic pathogen of 
the patient. The diagnostic value of Aspergillus spp. in respiratory samples is not straightforward, 
principally because of difficulties distinguishing colonization from disease. In our series, 42% (69 of 165) 
of the isolated Aspergillus spp. was considered to represent colonization, and the most common colonized 
species was A. niger, followed by A. versicolor, A. fumigatus, A. terreus, A. flavus, A. sydowii, and A. 
nidulans. Although A. niger is less virulent than A. fumigatus and A. flavus, it can occasionally cause IPA, 
CNPA, or ABPA, and may colonize respiratory tracts of patients with chronic lung diseases [8, 23, 24]. 
From our analyses, A. niger was most frequently associated with patients diagnosed with ABPA (40%), but 
for all other forms of pulmonary aspergillosis, A. fumigatus was the dominant isolate. Although A. 
fumigatus is the most pathogenic Aspergillus spp., it may also colonize respiratory tracts without leading to 
clinical symptoms of aspergillosis, as was observed in 16% of cases. 
The reported frequency of Aspergillus spp. colonization ranges from 36–91% of clinical cases, 
depending on the patient population studied [9–16]. Perfect et al. [11] reported that approximately 50% of 
Aspergillus-positive cultures represented colonization, with A. fumigatus (63%) representing the dominant 
colonizing species, followed by A. niger (14%), A. flavus (9%), A. nidulans (1%), A. terreus (1%), and 
other species (4%). Although the general trend for the colonizing species in our data was similar, the 
prevalence of A. fumigatus (41%) and A. niger (32%) was much more equal. The difference in the 
incidence of colonizing species between the two studies is considered to be mainly a result of the study 
periods and patients. Our data were obtained between 1998 and 2009, whereas Perfect et al. [11] conducted 
their surveillance in 1995. As our data between 1998 and 2004 more closely resembled that of Perfect et al. 
[11] with respect to the distribution of A. fumigatus (58.2%) and A. niger (20.9%), it appears that A. niger is 
becoming more prevalent in respiratory tract samples, a speculation that is consistent with a reported 
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increase in the frequency of A. niger isolation in recent years [27–29]. Colonization may represent transient 
passage in the airway, as long-term benign carriage is typically observed in patients with localized 
structural or functional pulmonary deficits; however, it may be a warning sign preceding overt Aspergillus 
infection [14, 15]. 
CNPA, which was originally reported by Binder et al. [7], has been widely used to characterize a 
syndrome complex consisting of slowly progressive cavitary lung disease, chronic respiratory symptoms, 
and the presence of precipitating antibodies to Aspergillus spp. A few reports related to CNPA have 
described direct invasion of pulmonary parenchyma by hyphal elements [7, 23, 30]; however, the majority 
of reports have not found clear evidence of parenchymal invasion despite progressive tissue damage. 
Denning et al. [31] proposed that chronic cavitary pulmonary aspergillosis (CCPA) accounts for cases in 
which there is formation and expansion of multiple cavities over time. Furthermore, they proposed that the 
term CNPA be reserved for cases in which hyphal invasion of tissue is demonstrated, such as the subacute 
form of IPA. The majority of our patients with CNPA may have been diagnosed with CCPA, because the 
pathological appearance of hyphal invasion had not been examined. In our patients with CNPA, A. 
fumigatus was the most commonly isolated species (54%), followed by A. niger (24%), A. terreus (10%), A. 
versicolor (6%), A. flavus (4%), and A. nidulans (2%). This result is consistent with that of Perfect et al. 
[11] who reported that the most common Aspergillus species identified in patients with CNPA was A. 
fumigatus (80%), followed by A. niger (10%), A. flavus (2%), and other species (8%). 
The profile of Aspergillus spp. isolated from patients with aspergilloma was similar to that from 
patients with CNPA, and consisted of A. fumigatus (68%), A. niger (12%), A. terreus (12%), A. versicolor 
(4%), and A. nidulans (4%). Perfect et al. [11] reported that the most common Aspergillus species identified 
in patients with aspergilloma was A. fumigatus (69%), followed by A. niger (13%), A. flavus (2%), and 
other species (5%). 
The majority of IPA is caused by A. fumigatus, with the second most frequent pathogenic species 
being A. flavus and, to a lesser extent, A. niger and A. terreus [8, 32]. In our retrospective study, the most 
common Aspergillus species identified in patients with IPA was A. fumigatus (80%), followed by A. niger 
(9%) and A. flavus (9%). Perfect et al. [11] reported that A. fumigatus (67%) was most commonly isolated, 
followed by A. flavus (16%), A. niger (5%), A. terreus (3%), and A. nidulans (1%). 
ABPA is an allergic pulmonary disorder caused by hypersensitivity to Aspergillus spp., and A. 
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fumigatus is the primary causal organism. In our series, the isolated Aspergillus spp. from patients with 
ABPA were A. niger (40%), A. fumigatus (30%), A. versicolor (20%), and A. terreus (10%). Since we did 
not test allergic reactions to non-fumigatus Aspergillus spp., isolates other than A. fumigatus could not be 
confirmed as the etiologic antigen to ABPA. However, ABPA due to A. flavus, A. nidulans, A. terreus or A. 
niger has been reported [33–35]. Recently, Benndorf et al. [36] identified IgE antibodies that exclusively 
recognize spore extracts from A. versicolor in sera from patients, and also found a relationship between 
increased spore concentration in indoor air or visible mould affection and a positive reaction of sera to A. 
versicolor. As the isolation of A. versicolor in respiratory samples is generally considered as colonization 
[37–40], the possibility that it is an etiologic agent for aspergillosis, including ABPA, cannot be denied. 
Two limitations of this study warrant mention. First, as histopathological observations were not 
available for most patients, we could not differentiate between CNPA and other forms of chronic 
pulmonary aspergillosis, including CCPA. Second, since immunological tests, such as IgG or IgE antibody 
titer and antigen tests for non- fumigatus Aspergillus spp. were not available, isolates other than A. 
fumigatus could not be confirmed as the etiologic agent of disease in chronic pulmonary aspergillosis 
including ABPA. 
In conclusion, the results of our study show that isolation of Aspergillus spp. from respiratory samples 
does not confirm that they represent the etiologic pathogen, because airway colonization by Aspergillus spp. 
is a common feature in patients with chronic lung disease. Even if Aspergillus spp. is isolated in a patient 
with clinically diagnosed aspergillosis, the colonizing species may not be associated with mycotic disease. 
The examined clinical, radiological, and microbiological data from 139 patients positive for Aspergillus spp. 
isolates did not allow differentiation between infection and colonization in several cases. It is therefore 
considered that repeated isolation of the identical Aspergillus sp. and detection of anti-Aspergillus 
antibodies and/or Aspergillus circulating antigens in sera are needed to conclude that an isolated species 
represents the etiological organism in immunocompetent or mildly immunocompromised individuals. 
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Table 1. Clinical characteristics of patients with Aspergillus-positive cultures from respiratory samples 
NOTE.  CNPA, chronic necrotizing pulmonary aspergillosis; IPA, invasive pulmonary aspergillosis; ABPA, allergic 
bronchopulmonary aspergillosis; COPD, chronic obstructive pulmonary disease    
a A patient may have more than one characteristic 
Characteristic a 











Age in years, range (mean) 19-83 (64.7) 46-84 (68.7) 18-83 (58.8) 27-80 (51.6) 20-85 (61.8) 
Sex (male/female) 29/8 15/7 7/3 4/4 26/36 
Underlying lung disease      
COPD 14 (38) 9 (41) 1 (10)  11 (18) 
Non-tuberculous mycobacteriosis 13 (35) 1 (5)  1 (13) 10 (16) 
Tuberculosis 9 (24) 9 (41)  1 (13) 14 (23) 
Lung cancer survivor 5 (14) 2 (9)  1 (13) 11 (18) 
Bullae or pneumothorax 4 (11) 3 (14)   4 (6) 
Interstitial pneumonia 2 (5) 1 (5) 1 (10)  10 (16) 
Pneumoconiosis 2 (5) 1 (5)   2 (3) 
Bronchial asthma 1 (3)   7 (88) 1 (2) 
Other lung diseases  2 (9) 2 (20)  8 (13) 
Immunosuppressive condition      
Solid organ cancer 6 (16)  1 (10)  4 (6) 
Hematologic malignancy 1 (3)  5 (50)  4 (6) 
Diabetes mellitus 11 (30)  2 (20)  2 (3) 
Chronic liver disease 3 (8)  2 (20)  2 (3) 
Chronic kidney disease 1 (3)    3 (5) 
Collagen vascular disease     10 (16) 
Atopic disease    5 (63)  
Other diseases 2 (5)     
Corticosteroid use 3 (8)  5 (50)  12 (19) 
Cytotoxic drug use   5 (50)  2 (3) 
Bone marrow transplant   1 (10)   
In-hospital mortality 6 (16) 1 (5) 8 (80) 0 (0) 1 (2) 
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NOTE.  CNPA, chronic necrotizing pulmonary aspergillosis; IPA, invasive pulmonary aspergillosis; ABPA, allergic 
bronchopulmonary aspergillosis 
 














A. fumigatus 27 (54) 17 (68) 9 (82) 3 (30) 11 (16) 67 (41) 
A. niger 12 (24) 3 (12) 1 (9) 4 (40) 33 (48) 53 (32) 
A. versicolor 3 (6) 1 (4)  2 (20) 14 (20) 20 (12) 
A. terreus 5 (10)   1 (10) 4 (6) 10 (6) 
A. flavus 2 (4) 3 (12) 1 (9)  3 (4) 9 (5) 
A. nidulans 1 (2) 1 (4)   1 (1) 3 (2) 
A. sydowii     2 (3) 2 (1) 
Not identified     1 (1) 1 (0.6) 
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NOTE.  CNPA, chronic necrotizing pulmonary aspergillosis; IPA, invasive pulmonary aspergillosis; ABPA, allergic bronchopulmonary 
aspergillosis 














A. fumigatus+ A. niger 3 1  1 2 7 
A. niger+ A. versicolor 1    2 3 
A. fumigatus+ A. terreus 1     1 
A. fumigatus+ A. flavus   1   1 
A. niger+ A. flavus     1 1 
A. niger+ A. terreus    1  1 
A. niger+ A. sydowii     1 1 
A. terreus +A. nidulans 1     1 
A. fumigatus+ A. niger+ A. versicolor 1     1 
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Table 4. Metachronously isolated Aspergillus species according to clinical condition 
Aspergillus species 
Clinical condition 
(No. of patients) 
A. fumigatus → A. niger CNPA (n=2) 
A. niger → A. fumigatus CNPA (n=1) 
A. niger → A. fumigatus → A. terreus → A. versicolor CNPA (n=1) 
A. niger → A. fumigatus → A. nidulans Aspergilloma (n=1) 
A. terreus → A. fumigatus Colonization (n=1) 






Figure 1. Comparison of Aspergillus spp. isolated during 1998–2004 and 2005–2009 from adults in a 
pneumology ward. A. fumigatus was the most commonly isolated species between 1998 and 2004; however, 
between 2005 and 2009 its frequency of isolation had decreased by approximately half, while A. niger 
increased approximately two fold to become the most commonly isolated species. 
 
